Evaxion A (EVAX) Accounts Payables (2019 - 2025)
Evaxion A (EVAX) reported Accounts Payables of $2.2 million for Q4 2025, down 26.35% on a YoY basis from $3.0 million in Q4 2024, and down 12.42% quarter-over-quarter from $2.5 million in Q2 2025.
Evaxion A (EVAX) Accounts Payables (2019 - 2025) Analysis & Trends
Evaxion A has reported Accounts Payables for 7 years, with the latest figure at $2.2 million in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables fell 26.35% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 26.35% YoY), and the FY2025 full-year result was $2.2 million, down 26.35% from the prior year.
- Accounts Payables for Q4 2025 stood at $2.2 million, down from $2.5 million in the prior quarter.
- The five-year high for Accounts Payables was $3.4 million in Q1 2021, with the low at $538000.0 in Q3 2021.
- Historically, Accounts Payables has averaged $2.3 million across 5 years, with a median of $2.5 million in 2022.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 57.15% — and 2023, when it tumbled 30.91%.
- Evaxion A's Accounts Payables stood at $2.8 million in 2021, then declined by 26.79% to $2.1 million in 2022, then rose by 28.97% to $2.7 million in 2023, then climbed by 10.38% to $3.0 million in 2024, then slipped by 26.35% to $2.2 million in 2025.
- The last three Accounts Payables figures came in at $2.2 million (Q4 2025), $2.5 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Dec 31, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 538,000.00 |
| Jun 30, 2021 | 1.55 Mn |
| Mar 31, 2021 | 3.41 Mn |
| Dec 31, 2020 | 3.67 Mn |
| Dec 31, 2019 | 646,000.00 |